Related Experiment Video
Updated: Aug 9, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Should episode-based economic profiles be risk adjusted to account for differences in patients' health risks?
1Institute for Health Policy, Edmund S. Muskie School of Public Service, University of Southern Maine, ME 04101-9300, USA.
Objective:
To determine whether additional risk adjustment is necessary in economic profiling of physicians when claims data are already grouped into episodes of care, and to measure effects of risk adjustment on cost efficiency rankings of physicians.
Data Sources:
Four years of inpatient, outpatient, professional, and pharmacy claims data from a mixed model HMO.
Study Design:
Claims data were processed through Symmetry Health Data Systems' episode treatment group (ETG) grouper to define episodes of care and Symmetry's episode risk group (ERG) software to define measures of patients' health risk scores. For each episode type (ETG), ETG-mean expected costs were calculated as the mean costs of all episodes of that type, and risk-adjusted expected costs were calculated using three alternative risk model formulations.
Data Collection:
Within specialties, physicians were ranked from most cost efficient to least cost efficient, based on standardized difference between actual and expected costs. ETG-mean based rankings were compared with risk-adjusted rankings. Analyses were performed for cardiologists, family practitioners, general surgeons, and neurologists.
Principal Findings:
With all three risk models, risk scores were essentially unrelated to episode costs in approximately three-fourths of episode categories (ETGs). In a sample of ETGs for which risks-costs relationships appeared to exist, split sample validation showed the relationships to be unstable or spurious in all except one ETG. Within specialties, risk-adjusted cost efficiency rankings differ little from ETG-mean adjusted rankings.
Conclusions:
Depending upon the purpose for which economic profiling is performed, additional risk adjustment, beyond that already provided by episode grouping, may be unnecessary. Additional research may be needed to identify and validate ETG-level relationships between patient risks and episode costs.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Kaplan-Meier Approach
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Relative Risk
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Bias in Epidemiological Studies
